Forgot Password?
If you have a user ID already and cannot login, contact Technical Support
You can begin the registration process by clicking here
Effective July 1, 2019 - Please note that IIT and SRA have been transitioned to the Sanofi Investigator Sponsored Studies Web portal.
If you need to access previously submitted applications or to submit a new request, please log into
If you need to access your previously submitted application please log in using your existing User ID and Password.

Should you encounter any issues please contact the Envision Helpdesk at

Welcome to Bioverativ's Medical Research Submission Portal

This website will enable you to submit your Medical Research proposal for review, track the progress of your existing proposal, and report on ongoing studies.

Submit your research proposal today

Study proposals are submitted to Bioverativ through this online submission portal. Our review process and considerations for your proposal are outlined below. For detailed information on how to prepare your proposal, submission requirements, and to check on upcoming submission deadlines, please visit the Medical Research website at
Bioverativ supports research in a number of therapeutic areas. A complete study proposal must be submitted to Bioverativ for review by our cross-functional committee. It should contain a well thought out study rationale, clear primary objective with supportive endpoints, cohesive study design, statistical analysis plan and sample size calculation, and study and publication timelines. Our submission form(downloadable here) can help you prepare. Additionally, for financial support, an itemized budget on Bioverativ’s template(downloadable here) must be provided with the proposal.
Bioverativ awards research support on a highly competitive basis. All proposals are reviewed by a cross-functional Review Committee, which includes medical directors, drug safety, scientists, biostatisticians, and experts in health outcomes and pharmacoeconomics. The review cycle depends on the proposal type.